Kangji Medical Holdings (HKSE:09997) EBIT : HK$646 Mil (TTM As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Kangji Medical Holdings EBIT?

Kangji Medical Holdings's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2023 was HK$348 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$646 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Kangji Medical Holdings's annualized ROC % for the quarter that ended in Dec. 2023 was 35.64%. Kangji Medical Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 117.74%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Kangji Medical Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 10.07%.

Kangji Medical Holdings EBIT Historical Data

The historical data trend for Kangji Medical Holdings's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kangji Medical Holdings EBIT Chart

Kangji Medical Holdings Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT

Get a 7-Day Free Trial

435.30

367.62

654.71

630.97

646.45

Kangji Medical Holdings Semi-Annual Data
	Dec17	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EBIT	Get a 7-Day Free Trial							367.63	229.18	412.64	298.01	348.44

Competitive Comparison of Kangji Medical Holdings's EBIT

For the Medical Instruments & Supplies subindustry, Kangji Medical Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kangji Medical Holdings's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Kangji Medical Holdings's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Kangji Medical Holdings's EV-to-EBIT falls into.

Kangji Medical Holdings EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$646 Mil.

Kangji Medical Holdings (HKSE:09997) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Kangji Medical Holdings's annualized ROC % for the quarter that ended in Dec. 2023 is calculated as:

	ROC % (Q: Dec. 2023 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Jun. 2023 )	+	Invested Capital (Q: Dec. 2023 ))	/ count )
=	638.916 * ( 1 - 29.76% )	/	( (977.49	+	1540.611)	/ 2 )
=	448.7745984	/	1259.0505
=	35.64 %

where

	Invested Capital		(Q: Jun. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	4597.651	-	389.074	-	( 3296.202	-	max(0, 397.728	-	3628.815	+	3296.202	))
=	977.49

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	4663.674	-	182.945	-	( 2940.118	-	max(0, 208.719	-	3697.726	+	2940.118	))
=	1540.611

Note: The Operating Income data used here is two times the semi-annual (Dec. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Kangji Medical Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Dec. 2023 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Jun. 2023		Q: Dec. 2023
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	696.888	/	( ( (319.217 + max(-82.733, 0))	+	(313.029 + max(551.492, 0)) )	/	2 )
=	696.888	/	( ( 319.217	+	864.521 )	/	2 )
=	696.888	/	591.869
=	117.74 %

where Working Capital is:

	Working Capital		(Q: Jun. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(185.012	+	123.322	+	-0.0010000000002037)	-	(389.074	+	0	+	1.992)
=	-82.733

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(246.684	+	115.071	+	391.776)	-	(182.945	+	0	+	19.094)
=	551.492

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Kangji Medical Holdings's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Dec. 2023 )
	=	646.454	/	6422.342
	=	10.07 %

Kangji Medical Holdings EBIT Related Terms

Thank you for viewing the detailed overview of Kangji Medical Holdings's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Kangji Medical Holdings (HKSE:09997) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Kangji Medical Holdings Ltd (HKSE:09997) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

50J:Germany

Address

No. 1668 Chunjiang East Road, Tonglu Economic Development Zone, Zhejiang Province, Hangzhou, CHN

Website

https://www.kangjimedical.com

Kangji Medical Holdings Ltd is engaged in the production and sales of minimally invasive surgical instruments and accessories. The company offers a product portfolio to provide physicians and hospitals with one-shop and tailored surgical solutions for four surgical specialties OBGYN, general surgery, urology, and thoracic surgery. It manufactures and sells both disposable and reusable products. Its product portfolio includes disposable trocars, polymer ligation clips, disposable electrocoagulation forceps, and reusable trocar and forceps. It derives the majority of its revenue from Mainland China.

Kangji Medical Holdings (HKSE:09997) Headlines

No Headlines